Abstract: Nonresolving inflammation, a hallmark of underlying severe inflammatory processes such as sepsis, acute respiratory distress syndrome and multiple organ failure is a major cause of admission to the intensive care unit and high mortality rates. Many survivors develop new functional limitations and health problems, and in cases of sepsis, approximately 40% of patients are rehospitalized within three months. Over the last few decades, better treatment approaches have been adopted. Nevertheless, the lack of knowledge underlying the complex pathophysiology of the inflammatory response organized by numerous mediators and the induction of complex networks impede curative therapy. Thus, increasing evidence indicates that resolution of an acute inflammatory response, considered an active process, is the ideal outcome that leads to tissue restoration and organ function. Many mediators have been identified as immunoresolvents, but only a few have been shown to contribute to both the initial and resolution phases of severe systemic inflammation, and these agents might finally substantially impact the therapeutic approach to severe inflammatory processes. In this review, we depict different resolution mediators/immunoresolvents contributing to resolution programmes specifically related to life-threatening severe inflammatory processes.
released from damaged and necrotic cells to induce the recruitment of neutrophils via their cell-surface DAMP receptors-the so-called pattern recognition receptors (PRRs). Known PRRs are categorized into the main classes: Toll-like receptors, C-type lectin receptors, and retinoic acid-inducible gene 1-like receptors. 10 Moreover, DAMPs induce the exposure of hydrogen peroxide (H 2 O 2 ) to activate the early recruitment of neutrophils through the SRC family kinase LYN. 7 For further neutrophil recruitment, DAMPs activate the production of proinflammatory mediators such as CXC-chemokine ligand 8 (CXCL8) family chemokines and lipid mediators, e.g. leukotriene B 4 (LTB 4 ), within the surrounding immune cells. 11, 12 In turn, the activated neutrophils induce the release of CXCL8 family chemokines and LTB 4 to mediate neutrophil migration to the site of injury. Further components of the inflammatory response involve the rapid activation of the complement system, particularly with the increased generation of C3a and C5a. 13, 14 These factors lead to the extended participation of immune competent cells, including macrophages (MΦ), dendritic cells, mast cells and T-cells.
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Onset of Nonsterile Inflammation
In addition to the concept of DAMPs, pathogen-associated molecular patterns (PAMPs) expressed by pathogens and PRRs characterize a major variable in the control of the initial immune response to nonsterile inflammation. 19 From a molecular viewpoint, the initial inflammatory response to infection is largely similar to that of sterile inflammation caused by trauma, ischaemic reperfusion injury or burns. 20 This point may explain the difficulties in making precise diagnoses and finally elucidating a better targeted therapy based on only clinical signs.
Resolution and the Main Players
The ideal outcomes of an acute inflammatory response are the termination of inflammation, prevention of excessive 
Role of the Vagus Nerve in Resolution
Increasing evidence suggests that the nervous system and immune system interact and communicate to regulate the host immune response. These inflammatory reflex circuits comprise afferent nerves that sense peripheral inflammation, injury and infection and transmit the signal to the brain stem, which in turn activates efferent nerves to relay signals to modulate immune responses.
Cholinergic Anti-Inflammatory Pathway
A prominent inflammatory reflex involves the vagus nerve, which is termed the cholinergic anti-inflammatory pathway. 35 Here, sensory vagus nerves can be activated by inflammatory mediators such as cytokines via their PRR and transmit the signal to the brain stem, resulting in stimulation of efferent vagus nerve fibres. These signals from the vagus nerves are delivered to splenic nerve fibres, which induce the release of acetylcholine (ACh) from T-cells. Subsequent activation of the α7 nicotinic ACh receptor (α7nAChR) on MΦs inhibits the synthesis of proinflammatory mediators and thus suppresses the inflammatory response. [35] [36] [37] Hence, vagotomy intensifies inflammatory responses and increases tissue damage in conditions such as colitis 38 and pancreatitis. 39 
Vagus Nerve During Resolution of Sterile and Infectious Peritonitis
Recently, the vagal regulation of the resolution phase and SPM generation was revealed. 40, 41 In one study, 40 unilateral vagotomy resulted in intensified sterile murine peritonitis (increased leucocyte numbers, PMNs and enhanced levels of myeloperoxidase (MPO), cytokines and chemokines) and delayed resolution with a longer resolution interval R i 30 of 37 h compared to 24 h in sham-operated mice. Furthermore, vagotomy shifted the lipid mediator profile in exudates during sterile peritonitis by stimulating the synthesis of proinflammatory lipid mediators such as leukotriene B 4 (LTB 4 ) while inhibiting the generation of immunoresolvents such as Resolvin D1 (RvD1). 40 Interestingly, the administration of RvD1 rescues this hyperinflammatory response in vagotomized mice by limiting excessive PMN infiltration and regulating monocyte recruitment and cytokine production. In addition, the vagus nerve controls the expression of the neuronal guidance protein (NGP) Netrin-1, 40 which regulates not only neuronal development but also inflammatory responses. [42] [43] [44] [45] After vagotomy and peritonitis, the expression of Netrin-1 was substantially decreased, indicating an involvement of Netrin-1 in this neuroimmune interaction. 40 During peritonitis, Netrin-1 shortens the time required for resolution and promotes the synthesis of endogenous proresolving mediators. Notably, deficient Netrin-1 expression in Netrin-1 heterozygous mice delayed the resolution time compared to that in wild-type animals, and acceleration with an additional injection of RvD1 was not observed in Netrin +/-mice like it was in wild-type mice, suggesting a bidirectional interaction between Netrin-1 and resolvins. In human MΦs, Netrin-1 upregulated the biosynthesis of SPMs, the efferocytosis of apoptotic PMNs and, synergistically with RvD1, the phagocytosis rate of zymosan A particles. Overall, this study illustrated a novel collaboration of Netrin-1 and RvD1, which are both regulated by the vagus nerve, during the resolution of acute sterile inflammation. In another report, vagotomy decreased peritoneal immunoresolvent levels and delayed the resolution of inflammation during infectious E. coli peritonitis. 41 In this work, Dalli and colleagues demonstrated that vagotomy delayed resolution processes through the dysregulation of tissue retinoic acid-related orphan receptor γ t (RORγt) CD335 + group 3 innate lymphoid cells (ILC3) and changes in the lipid mediator profile of resident peritoneal MΦs. Vagotomy decreases PCTR1 levels before exposure to E. coli infection. Treatment of vagotomized mice with PCTR1 recovered the macrophage phenotypes and partly protected them from infectious phenomena. The authors also showed that acetylcholine, a crucial transmitter in the vagal response, controls the PCTR biosynthetic pathway in ILC3s, which in turn impacts the resident phenotype of peritoneal MΦs.
Role of the Sympathetic Nerve in Resolution
Efforts to better understand inflammatory reflex circuits and the neural regulation of immunity revealed that the classic neuronal terminology of sympathetic and parasympathetic neurons is inaccurate and limited. Cooperation among somatosensory, sensory autonomic and efferent neurons via neurotransmitters such as acetylcholine and catecholamines was demonstrated in some circuits. 46 
Sympathetic Nerve in Resolution and Tissue Regeneration
Thus, a recent report highlighted a novel facet of inflammatory reflexes in that adrenergic nerve fibres of the sympathetic nervous system together with the NGP Repulsive Guidance Molecule A (RGM-A) regulate the resolution of acute inflammation and promote tissue regeneration (Figure 2 ). 47 The protein RGM-A was shown to substantially influence the initial phase of acute inflammation and the pathobiology of autoimmune encephalomyelitis. 43 The adrenergic nerve together with the neuronal guidance protein RGM-A activate resolution programmes. RGM-A enhances the expression of the β2 adrenergic receptor (β2AR) on human MΦs, and activation of β2AR, in turn, increases RGM-A expression on MΦs. This interaction of the β2 adrenergic receptor and RGM-A signalling indicates a stronger reduction in PMN and proinflammatory cytokine levels and a stronger increase in MΦ efferocytosis and phagocytosis compared to that achieved with one agent alone, ultimately resulting in the generation of proresolving mediators. Abbreviations: AKT, protein kinase B; ALX, N-formyl peptide receptor 2; GPR32, G protein-coupled receptor 32; MФ, macrophage; M1, classically activated/type 1 proinflammatory macrophages; M2, alternatively activated/type 2 anti-inflammatory macrophages; mTOR, mammalian target of rapamycin; NF-κB, nuclear factor kappa-lightchain-enhancer of activated B cells; PI3K, phosphoinositide 3-kinase; PMN, polymorphonuclear leukocytes; SPM, specialized proresolving mediator. and the β 2 AR agonist induces an even stronger promotion of the resolution as that achieved with one substance alone, as demonstrated by the biosynthesis of immunoresolvents. Chemical sympathectomy, however, inhibits the resolution during acute peritonitis, as reflected by the enhanced infiltration of PMNs and classical monocytes, decreased clearance of PMNs and generation of SPMs. Additional administration of RGM-A, however, rescues this hyperinflammatory response to chemical sympathectomy by inhibiting the elevated PMN influx and controlling monocyte extravasation as well as the biosynthesis of immunoresolvents. Additionally, RGM-A and/ or the β 2 AR agonist inhibit NF-κB signalling and activate RICTOR as well as PI3K/AKT signalling pathways in peritoneal monocytes.
Role of Neuronal Guidance Proteins in Resolution
The superfamily of neuronal guidance proteins (NGPs) was originally discovered in the developing nervous system and shown to guide growing axons by chemoattraction and chemorepulsion. Over the last few years, NGPs have been identified in peripheral tissues and shown to modulate immune reactions, especially leucocyte migration, through their chemoattractive and chemorepulsive properties. However, recent studies have highlighted various additional immune functions of NGPs in acute and chronic inflammation conditions as well as during the resolution (Figure 3 ). 43 
Function of Netrin-1 During Resolution and Regeneration of Sterile Liver Inflammation
The NGP Netrin-1 promotes the resolution of acute inflammation not only during peritonitis 40 but also during acute liver inflammation in ischaemia/reperfusion injury (IR). 42 The disruption of blood flow (ischaemia) followed by its restoration (reperfusion) results in an intense inflammatory response and represents a major adverse complication in the liver during surgery, transplantation and haemorrhagic shock. 50 Interestingly, in Netrin-1-deficient mice, the infiltration of PMNs is enhanced, while nonclassical monocytes and thus efferocytosis are inhibited in the late phase of liver IR compared to that in wild-type (WT) animals, indicating a delayed resolution. 42 WT mice with Netrin-1 during the ischaemic phase, however, promotes the resolution of liver inflammation by limiting the PMN and classical monocyte numbers, increasing nonclassical monocytes and consequently increasing the MΦ uptake of apoptotic PMNs. Notably, Netrin-1 induces resident MΦs of the liver, Kupffer cells, and their efferocytosis rate. When Netrin-1 is administered in the resolution phase, its stimulating effects on resolution and regeneration during hepatic injury are even stronger than those exhibited at other phases of administration. Furthermore, Netrin-1 is expressed on human MΦs and robustly stimulates the phagocytosis rate of apoptotic PMNs. Netrin-1 not only promotes the biosynthesis of immunoresolvents such as LXA 4 during liver inflammation but also stimulates the expression of key growth factors of liver regeneration, such as hepatocyte growth factor (HGF), heparin-binding epidermal growth factor (HB-EGF) and its receptor EGFR. Additionally, the expression of angiogenic vascular endothelial growth factor A (VEGF-A) and its receptors VEGF-R1 and VEGF-R2 as well as the proliferation rate of hepatocytes are robustly increased by Netrin-1 treatment compared to those in controls. 42 Together, the results of this study reveal a novel role of the NGP Netrin-1 during the onset, resolution and regeneration phases of acute liver inflammation. 42 
Impact of Neogenin on Inflammation Resolution and Tissue Regeneration
The receptor of Netrin-1 and RGM-A, Neogenin 1 (Neo1), plays an important role during the onset of acute inflammation. [51] [52] [53] A recent report identified a previously unknown role of Neo1 during the resolution of inflammation and during regeneration. 54 Functional inhibition of Neo1 stimulated the apoptosis of human PMNs and activated find-me signals on apoptotic PMNs as well as findme and eat-me receptors on human MΦs. Together with the increased phagocytosis rate of MΦs and the stimulated expression of G-protein coupled receptors (GPCRs) for SPMs on human MΦs, the inhibition of Neo1 promotes resolution. Consistently, the lack of Neo1 inhibits the recruitment of PMNs while stimulating their apoptosis as well as the efferocytosis rate of MΦs and the biosynthesis of immunoresolvents such as LXA 4 and Mar1 in a murine peritonitis model compared to those in WT controls. Notably, the expression of Neo1 is restricted to classical Ly6C hi monocytes in the peritoneal cavity during acute inflammation, while Neo1 deficiency elicits a phenotype switch towards nonclassical Ly6C lo monocytes by stimulating PI3K/AKT and inhibiting the TGFβ signalling pathway. Endogenous Neo1 repression stimulates tissue repair and regeneration by enhancing IL-10 and TGFβ levels and promoting the proliferative response in the peritoneum during acute inflammation. Functional exogenous blockade of Neo1 with an antibody mitigates the onset phase of acute peritonitis and accelerates the resolution. Additionally, in a cohort of critically ill paediatric ICU (PICU) patients, the plasma levels of Neo1 were shown to correlate with abdominal compartment syndrome (ACS), the intraabdominal hypertension (IAH) grade, the Pediatric Risk of Mortality III (PRISM-III) score, the length of stay in the ICU and survival. This report identified Neo1 as a regulator of the resolution of inflammation and tissue regeneration as well as a predictor of the severity and survival of critically ill paediatric patients. 54 
Role of Nutrition in Resolution Ω-3-Enriched Lipid Emulsions for Critically Ill Patients
Ideally, the onset phase of acute inflammation is followed by the resolution phase, which is actively mediated by immunoresolvents derived from AA as well as the two Omega-3 (Ω-3) fatty acids DHA and EPA. Hence, the administration of lipid emulsions (LEs) with Ω-3 supplementation was evaluated in critically ill patients to identify a possible reduction of inflammation and improvement of clinical outcomes. [55] [56] [57] The results, however, were controversial, and due to the lack of data, no recommendation for the nutritional treatment of critically ill patients was made. 58 Additional debates remain about the composition and amount as well as the time point of administration and indication for parenteral LEs. 58 The shortage of data about the effects of nutritional support extends to the possible impact of LEs during the initial and resolution phases as well as during tissue regeneration.
Ω-3-Enriched Lipid Emulsions in Sterile Peritonitis and Sepsis
However, a recent report highlights the role of Ω-3-enriched LEs (Ω-3 + LEs) containing long-and medium-chain fatty acids and fish oil (50:40:10) during the resolution of acute murine peritonitis and murine sepsis. 59 In a self-limited model of peritonitis, WT mice were treated with Ω-3 + LEs 24 h prior to zymosan A injection, resulting in robust decreases in infiltrating leucocytes such as PMNs, classical monocytes and MΦs, enhanced nonclassical monocyte numbers and phagocytosis rates, and reduced cytokine levels of IL-6 and keratinocyte chemoattractant (murine IL-8 homologue) compared to those in vehicle controls. Furthermore, Ω-3 + LEs decrease leucocyte adherence to the endothelium as well as their migration, whereas they stimulate the rolling velocity of leucocytes during murine peritonitis compared to that in controls as evaluated by intravital microscopy. Severe conditions such as sepsis due to infection or sterile injury, ischaemia/reperfusion injury and cancer are associated with metabolic and immune alterations, which can cause dysregulated inflammatory responses leading to organ dysfunction and a high morbidity and mortality. 58, 60 The treatment options for sepsis, however, are unspecific and concentrate on symptomatic therapy. 60 Körner and colleagues demonstrated that only dietary Ω-3 + LEs improved survival and protected against weight loss and hypothermia in a murine polymicrobial sepsis model compared to that in vehicle and Ω-3 − LEs controls. 59 In addi- 
Concluding Remarks
In translational terms, new evidence points to that excessive, uncontrolled inflammatory response can lead to tissue dysfunction and in extreme cases to tissue damage with loss of organ function. It is proven that the inflammatory response can be subdivided in three main phases: (1) the onset, (2) resolution and (3) post-resolution phase. 30, 61 Up to the present, we consider the acute inflammation as a temporal crescendo of the resolution mediators and decrescendo of the initiating inflammatory chemical mediators. As described above, upon initiation of an inflammatory event the innate immune system induces the tissueresident cells to perceive the inflammatory stimulus and to express inflammatory mediators such as chemokines, cytokines, classic eicosanoids, free radicals and vasoactive amins. 3, 61 This response is associated with the recruitment and accumulation of leukocytes in the affected tissues. In the course of this, the key characteristic programs of inflammation resolution become activated to achieve a state of tissue homeostasis. Firstly, the release of "stop signals" such as transcription factors, anti-inflammatory cytokines, miRNA genes and NGP 3, 43, 61 etc. is crucial to dampen the leukocyte accumulation. Inflammation-initiating molecules such as cyclooxygenase derived prostaglandin E 2 (PGE 2 ) or PGD 2 within the neutrophils convert through lipid-mediator class switching to anti-inflammatory and pro-resolving molecules, such as lipoxins, resolvins and protectins. 30 This PMN phenotype switch implies the strong connection between the initiation and resolution phase, because SPMs also induces MΦ phenotype reprograming toward a proresolving phenotype. 30, 61 The clearance or elimination of inflammatory cells can be further initiated by: reverse neutrophil migration, leukocyte apoptosis in the inflamed tissue, efferocytosis and phagocytosis. Thus, these processes indicate that the acute inflammatory response is a highly coordinated process in which the initiation and resolution phases are closely linked. The biological actions of immunoresolvents are important in the treatment of severe systemic disease, as the approach is altered from "combating inflammation" to "focusing and promoting inflammation resolution". 30 A deeper understanding of the complex pathophysiology of severe systemic diseases is elementary for generating curative approaches. Of substantial importance are mediators that have proven to exert potent proresolving effects on severe systemic models (Table 1) . Recently, specialized proresolving mediators, such as RvE1, RvD1-D5 and PD1, were identified as potent proresolving targets in lung injury, sterile and infectious peritonitis, colitis and sepsis. 30 The fact that some of these targets are currently being investigated in the clinic holds promise for new therapeutic approaches even in cases of severe systemic inflammation. However, the mechanisms, particularly the downstream pathways captured by these lipid mediators, have not been clearly elucidated, and additional investigations are needed to learn more about their specific effects and interactions with each other. An additional mediator class, NGPs, is becoming increasingly important in the therapeutic concepts underlying severe systemic inflammation. The peculiarity of NPGs lies in their influence of different and specific pathophysiological cornerstones. These events include the following: (1) alterations during the initial, resolution and regeneration phases of inflammation; (2) changes in the coagulation system, which can be associated with vessel barrier disorder and local cellular/tissue hypoxia; (3) dysregulation of the neuroendocrine system; and (4) changes in the function of immune cells that can manifest in immune paralysis. 5, 43, 47, 54, 62 In particular, the intersection of the neuronal system (vagus nerve and sympathetic nerve) with the NGP Netrin-1 or RGM-A in association with SPMs substantiates the broader impact on the inflammatory networks of severe inflammation. 40, 47 Data from basic science, preclinical and clinical/translational studies corroborate the variety of mediators influencing the network of resolution programmes. Therefore, it is of great importance to more closely investigate the mechanisms and effects of these and newly detected mediators on the pathophysiology of severe systemic inflammation to generate potential new treatment concepts. Abbreviations: PD1, protectin D1; RvD2-5, resolving D2-D5; RvE1, resolvin E1; RGM-A, repulsive guidance molecule A.
Dovepress
Publish your work in this journal
ImmunoTargets and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered. In addition, the journal will focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.
Submit your manuscript here: http://www.dovepress.com/immunotargets-and-therapy-journal
